- Home
- RCS vs SOPH Comparison
RCS vs SOPH Comparison
Compare RCS & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCS
- SOPH
- Stock Information
- Founded
- RCS 1994
- SOPH 2011
- Country
- RCS United States
- SOPH Switzerland
- Employees
- RCS N/A
- SOPH N/A
- Industry
- RCS Investment Managers
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RCS Finance
- SOPH Health Care
- Exchange
- RCS Nasdaq
- SOPH Nasdaq
- Market Cap
- RCS 279.8M
- SOPH 247.0M
- IPO Year
- RCS N/A
- SOPH 2021
- Fundamental
- Price
- RCS $7.50
- SOPH $3.55
- Analyst Decision
- RCS
- SOPH Strong Buy
- Analyst Count
- RCS 0
- SOPH 3
- Target Price
- RCS N/A
- SOPH $7.00
- AVG Volume (30 Days)
- RCS 141.1K
- SOPH 22.2K
- Earning Date
- RCS 01-01-0001
- SOPH 11-05-2024
- Dividend Yield
- RCS 10.12%
- SOPH N/A
- EPS Growth
- RCS N/A
- SOPH N/A
- EPS
- RCS N/A
- SOPH N/A
- Revenue
- RCS N/A
- SOPH $64,938,000.00
- Revenue This Year
- RCS N/A
- SOPH $7.70
- Revenue Next Year
- RCS N/A
- SOPH $20.61
- P/E Ratio
- RCS N/A
- SOPH N/A
- Revenue Growth
- RCS N/A
- SOPH 20.14
- 52 Week Low
- RCS $4.51
- SOPH $2.70
- 52 Week High
- RCS $6.31
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- RCS 46.09
- SOPH 47.86
- Support Level
- RCS $7.51
- SOPH $3.30
- Resistance Level
- RCS $8.07
- SOPH $3.66
- Average True Range (ATR)
- RCS 0.15
- SOPH 0.22
- MACD
- RCS -0.06
- SOPH 0.02
- Stochastic Oscillator
- RCS 0.86
- SOPH 64.20
About RCS PIMCO Strategic Income Fund Inc.
PIMCO Strategic Income Fund, Inc. operates as a closed-end management investment company. Its primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities. The Fund also seeks capital appreciation to the extent consistent with this objective.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.